All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

Endothelial Microvesicles and Soluble Markers of Endothelial Injury in Critically Ill Newborns

The result's identifiers

  • Result code in IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11120%2F18%3A43916955" target="_blank" >RIV/00216208:11120/18:43916955 - isvavai.cz</a>

  • Alternative codes found

    RIV/00064190:_____/18:N0000041 RIV/00216208:11110/18:10377541 RIV/00064165:_____/18:10377541

  • Result on the web

    <a href="https://doi.org/10.1155/2018/1975056" target="_blank" >https://doi.org/10.1155/2018/1975056</a>

  • DOI - Digital Object Identifier

    <a href="http://dx.doi.org/10.1155/2018/1975056" target="_blank" >10.1155/2018/1975056</a>

Alternative languages

  • Result language

    angličtina

  • Original language name

    Endothelial Microvesicles and Soluble Markers of Endothelial Injury in Critically Ill Newborns

  • Original language description

    Neonatal systemic inflammatory response and multiple organ dysfunction syndrome are the main postnatal insults influencing mortality and morbidity. Critically ill newborns with high predicted mortality are supported by extracorporeal membrane oxygenation (ECMO). Biomarkers of inflammatory response and endothelial injury can be used for early diagnosis and treatment of critical neonatal situations. The aim of our study was to explore plasma proteins and endothelial microvesicles as markers of inflammation and endothelial activation in newborns on ECMO and to compare them with healthy neonates. Thirteen newborns on ECMO and 13 healthy newborns were included in the study. Plasma soluble biomarkers were measured using multiplex immunoassay based on Luminex (R) xMAP multianalyte profiling platform. The total microvesicle count and plasma level of surface antigen-specific microvesicles were determined by flow cytometry. The plasma concentration of cell-derived microvesicles was measured using annexin-V labeling, and the endothelial origin of microvesicles was determined using lineage-specific antigen labeling of endothelial cell/microvesicle markers (endoglin/CD105, PECAM1/CD31, VEGFR2/CD309, and MadCAM1). Inflammatory markers (procalcitonin, IL-1 beta, IL-6, and IL-22) were increased in the ECMO group (P &lt; 0 01). The assessment of endothelial markers showed higher concentrations of endocan and angiopoietin-2 (P &lt; 0 01) in the ECMO group while VEGF in the ECMO group was significantly lower (P &lt; 0 01). In the ECMO group, the concentration of annexin-V-positive microvesicles (total microvesicles) and endothelial microvesicles expressing mucosal vascular addressin cell adhesion molecule 1 (MadCAM1) was increased (P = 0 05). In summary, we found increased concentrations of soluble inflammatory and endothelial markers in the plasma of critically ill newborns with multiple organ dysfunction. Increased plasma concentrations of microvesicles may reflect the activation or damage of blood cells and vasculature including endothelial cells. The measurement of cell membrane-derived microvesicles may be added to the panel of established inflammatory markers in order to increase the sensitivity and specificity of the diagnostic process in critically ill newborns.

  • Czech name

  • Czech description

Classification

  • Type

    J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database

  • CEP classification

  • OECD FORD branch

    30102 - Immunology

Result continuities

  • Project

    <a href="/en/project/NV16-27800A" target="_blank" >NV16-27800A: Endothelial injury in newborns: diagnostic significance of biomarkers and microparticles in diseases influencing neonatal mortality and morbidity</a><br>

  • Continuities

    S - Specificky vyzkum na vysokych skolach

Others

  • Publication year

    2018

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Data specific for result type

  • Name of the periodical

    Mediators of Inflammation

  • ISSN

    0962-9351

  • e-ISSN

  • Volume of the periodical

    2018

  • Issue of the periodical within the volume

    July

  • Country of publishing house

    US - UNITED STATES

  • Number of pages

    8

  • Pages from-to

    "Article 1975056"

  • UT code for WoS article

    000440502100001

  • EID of the result in the Scopus database

    2-s2.0-85058699386